Quốc gia: Ai-len
Ngôn ngữ: Tiếng Anh
Nguồn: HPRA (Health Products Regulatory Authority)
Amoxicillin trihydrate; potassium clavulanate
Dechra Regulatory B.V.
QJ01CR02
Amoxicillin trihydrate; potassium clavulanate
40, 10 mg/tablet
Tablet
POM: Prescription Only Medicine as defined in relevant national legislation
amoxicillin and enzyme inhibitor
Authorised
2011-10-28
Health Products Regulatory Authority 17 July 2020 CRN009SMX Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Clavudale 40 mg/10 mg tablets for cats and dogs 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 1 tablet contains: Active substances: Amoxicillin (as amoxicillin trihydrate) 40 mg Clavulanic acid (as potassium clavulanate) 10 mg Excipient: Erythrosine (E127) 0.75 mg For the full list of excipients see section 6.1. 3 PHARMACEUTICAL FORM Tablet. Pink, oblong, scored, meat flavoured tablets. The tablet can be divided into halves. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cats and dogs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment of bacterial infections susceptible to amoxicillin in combination with clavulanic acid where clinical experience and/or sensitivity testing indicates the product as the drug of choice. Uses include: Skin infections (including deep and superficial pyodermas) associated with _Staphylococcus _spp. and _Streptococcus _spp.; Infections of the oral cavity (mucous membrane) associated with _Clostridium _spp., _Corynebacterium _spp., _Staphylococcus _spp., _Streptococcus _spp., _Bacteroides_s pp. and _Pasteurella _spp.; Urinary tract infections associated with _Staphylococcus _spp., _Streptococcus _spp., _Escherichia coli _and _Proteus mirabilis_; Respiratory tract infections associated with _Staphylococcus _spp., _Streptococcus _spp., and _Pasteurella _spp. Gastrointestinal infections associated with _Escherichia coli_and _Proteusmirabilis._ 4.3 CONTRAINDICATIONS Do not use in rabbits, guinea pigs, hamsters and gerbils. Do not use in animals with known hypersensitivity to penicillin or substances of the ß-lactam group or any of the excipients. Do not use in animals with either oliguria or anuria associated with renal dysfunction. Do not use in cases of known resistance to the combination of amoxicillin and clavulanic acid. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None known. Health Products Regulatory Authority 17 July 202 Đọc toàn bộ tài liệu